Cambridge Antibody - Directors' Shareholdings
December 06 1999 - 2:02AM
UK Regulatory
RNS Number:9627B
Cambridge Antibody Tech Group PLC
3 December 1999
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
John Aston
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
CAT Group Employees Trustees Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of shares to IR approved staff share scheme and a grant of
options
7 Number of shares/amount of stock acquired:
500
8 Percentage of issued class:
0.0020%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary share
12 Price per share:
287p
13 Date of transaction:
3 December 199
14 Date company informed:
3 December 1999
15 Total holding following this notification:
2,127
16 Total percentage holding of issued class following this notification:
0.0084%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
3 December 1999
18 Period during which or date on which exercisable:
3 December 2002- 2 December 2006
19 Total amount paid (if any) for grant of the option:
Nil
20 Description of shares or debentures involved: class, number:
55,019 10p ordinary shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
287p
22 Total number of shares or debentures over which options held following
this notification:
198,983
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263 233
25 Name of company official responsible for making notification:
Diane Mellett
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
David Chiswell
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
As in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
CAT Group Employees Trustee Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of shares to IR approved staff share scheme and a grant of
options
7 Number of shares/amount of stock acquired:
500
8 Percentage of issued class:
0.0020%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
3rd December 1999
14 Date company informed:
3 December 1999
15 Total holding following this notification:
626,027
16 Total percentage holding of issued class following this notification:
2.46%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
3 December 1999
18 Period during which or date on which exercisable:
3 December 2002- 2 December 2006
19 Total amount paid (if any) for grant of the option:
Nil
20 Description of shares or debentures involved: class, number:
74,155 10p Ordinary shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
287p
22 Total number of shares or debentures over which options held following
this notification:
240,721
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263 233
25 Name of company official responsible for making notification:
Diane Mellett
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
David Glover
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
CAT Group Employees Trustee Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of shares to IR approved staff share scheme and a grant of
options
7 Number of shares/amount of stock acquired:
500
8 Percentage of issued class:
0.0020%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
2.87
13 Date of transaction:
3 December 1999
14 Date company informed:
3 December 1999
15 Total holding following this notification:
7,327
16 Total percentage holding of issued class following this notification:
0.029%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
3 December 1999
18 Period during which or date on which exercisable:
3 December 2002- 2 December 2006
19 Total amount paid (if any) for grant of the option:
Nil
20 Description of shares or debentures involved: class, number:
55,019 10p ordinary shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
287p
22 Total number of shares or debentures over which options held following
this notification:
174,983
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Diane Mellett
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
Kevin Johnson
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
As in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
CAT group Employees Trustees Limited
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Appropriation of shares to IR approved staff share scheme and a grant of
options
7 Number of shares/amount of stock acquired:
500
8 Percentage of issued class:
0.0020%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
10p ordinary shares
14 Date company informed:
10p ordinary shares
15 Total holding following this notification:
63,627
16 Total percentage holding of issued class following this notification:
0.25%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
3 December 1999
18 Period during which or date on which exercisable:
3 December 2002-2 December 2006
19 Total amount paid (if any) for grant of the option:
Nil
20 Description of shares or debentures involved: class, number:
118,324 10p ordinary shares
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
287p
22 Total number of shares or debentures over which options held following
this notification:
123,833
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Diane Mellett
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
James Foght
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
Non Beneficial Interest in Grant of shares in lieu of non exec renumeration to
Prudential Vector Healthcare Group
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
Prudential Vector Healthcare Group
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Prudential Vector Healthcare Group
7 Number of shares/amount of stock acquired:
1,742
8 Percentage of issued class:
0.0069%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
3 December 1999
14 Date company informed:
3 December 1999
15 Total holding following this notification:
2,742
16 Total percentage holding of issued class following this notification:
0.011%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
Sir Aaron Klug
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
As in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
as in 2
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Grant in lieu of non executive renumeration
7 Number of shares/amount of stock acquired:
1,742
8 Percentage of issued class:
0.0069%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
3 december 1999
14 Date company informed:
3 december 1999
15 Total holding following this notification:
38,057
16 Total percentage holding of issued class following this notification:
0.15%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
Peter Garland
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
as in 2
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
as in 2
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Grant in lieu of non executive director renumeration
7 Number of shares/amount of stock acquired:
3,484
8 Percentage of issued class:
0.014%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
December 3 1999
14 Date company informed:
December 3 1999
15 Total holding following this notification:
81,736
16 Total percentage holding of issued class following this notification:
0.32%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
Uwe Bicker
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
as in 2
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
Grant of shares in lieu of non executive renumeration
7 Number of shares/amount of stock acquired:
1,742
8 Percentage of issued class:
0.0069%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
3 December 1999
14 Date company informed:
3 December 1999
15 Total holding following this notification:
1,742
16 Total percentage holding of issued class following this notification:
0.0069%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
Paul Nicholson
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
as in 2
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
as in 2
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
grant in lieu of non executive renumeration
7 Number of shares/amount of stock acquired:
1,742
8 Percentage of issued class:
0.0069%
9 Number of shares/amount of stock disposed:
n/a
10 Percentage of issued class:
n/a
11 Class of security:
10p ordinary shares
12 Price per share:
287p
13 Date of transaction:
3 December 1999
14 Date company informed:
3 December 1999
15 Total holding following this notification:
3,742
16 Total percentage holding of issued class following this notification:
0.015%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Schedule 11 - Notification of interests of Directors and Connected Persons
1 Name of company:
Cambridge Antibody Technology
2 Name of director:
John Stocker
3 Please state whether notification indicates that it is in respect of
holding of the director named in 2 above or holding of that person's spouse or
children under the age of 18 or in respect of a non- beneficial interest:
As in 2 above
4 Name of registered holder(s) and, if more than one holder, the number of
shares held by each of them (if notified):
As in 2 above
5 Please state whether notification relates to a person(s) connected with
the director named in 2 above and identify the connected person(s):
6 Please state the nature of the transaction. For PEP transactions please
indicate whether general/single co PEP and if discretionary/non discretionary:
7 Number of shares/amount of stock acquired:
1,742
8 Percentage of issued class:
0.0069%
9 Number of shares/amount of stock disposed:
10 Percentage of issued class:
11 Class of security:
10p ordinary shares
12 Price per share:
287 pence
13 Date of transaction:
3 December 1999
14 Date company informed:
3 December 1999
15 Total holding following this notification:
2,742
16 Total percentage holding of issued class following this notification:
0.011%
If a director has been granted options by the company, please complete the
following fields:
17 Date of grant:
18 Period during which or date on which exercisable:
19 Total amount paid (if any) for grant of the option:
20 Description of shares or debentures involved: class, number:
21 Exercise price (if fixed at time of grant) or indication that price is to
be fixed at time of exercise:
22 Total number of shares or debentures over which options held following
this notification:
23 Contact name for queries:
John Aston
24 Contact telephone number:
01763 263233
25 Name of company official responsible for making notification:
Additional Information:
END
RDACCNCKFDDDKBK
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Catco Reinsurance Opport... (LSE:CAT)
Historical Stock Chart
From Jul 2023 to Jul 2024
